Literature DB >> 31705931

SUMOylation homeostasis in tumorigenesis.

Minyue Xie1, Jie Yu1, Shengfang Ge1, Jian Huang2, Xianqun Fan3.   

Abstract

Small ubiquitin-like modifier (SUMO), a critical regulatory modification protein, is involved in various biological processes, such as gene expression, genome maintenance and DNA damage repair (DDR). Numerous recent studies have revealed that disturbed SUMOylation and deSUMOylation homeostasis contribute to tumorigenesis. Abnormal alterations of key factors in the SUMO modification are closely related to cancer development and progression, indicating that the restoration of SUMOylation homeostasis may serve as a promising therapeutic strategy. In this review, we summarize the process and function of SUMOylation, clarify the 'dual-edged sword' functions of SUMOylation in diversified cancers and put forth future research prospects.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  SUMOylation; Tumorigenesis

Year:  2019        PMID: 31705931     DOI: 10.1016/j.canlet.2019.11.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

Review 2.  Post-translational modification of RAS proteins.

Authors:  Sharon L Campbell; Mark R Philips
Journal:  Curr Opin Struct Biol       Date:  2021-08-06       Impact factor: 6.809

Review 3.  The SUMO pathway in pancreatic cancer: insights and inhibition.

Authors:  Christian Schneeweis; Zonera Hassan; Markus Schick; Ulrich Keller; Günter Schneider
Journal:  Br J Cancer       Date:  2020-10-19       Impact factor: 7.640

4.  CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma.

Authors:  Xiaorong Yan; Dezhi Kang; Yuanxiang Lin; Songtao Qi; Changzhen Jiang
Journal:  Cell Commun Signal       Date:  2022-01-03       Impact factor: 5.712

5.  Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells.

Authors:  Guoxi Zhang; Junrong Zou; Jinglin Shi; Biao Qian; Kaiyang Qiu; Quanliang Liu; Tianpeng Xie; Zhihua He; Hui Xu; Yunfeng Liao; Yuting Wu; Yanmin Li; Guancheng Xiao; Yuanhu Yuan; Rihai Xiao; Gengqing Wu; Xiaofeng Zou
Journal:  Cell Death Dis       Date:  2021-11-09       Impact factor: 8.469

6.  Multi-Platform-Based Analysis Characterizes Molecular Alterations of the Nucleus in Human Colorectal Cancer.

Authors:  Wei Zhang; Minmin Wu; Xucan Gao; Chiyu Ma; Huixuan Xu; Liewen Lin; Jingquan He; Wanxia Cai; Yafang Zhong; Donge Tang; Min Tang; Yong Dai
Journal:  Front Cell Dev Biol       Date:  2022-02-21

Review 7.  Natural Products Against Renal Fibrosis via Modulation of SUMOylation.

Authors:  Peng Liu; Jing Zhang; Yun Wang; Chen Wang; Xinping Qiu; Dan-Qian Chen
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

Review 8.  A Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity.

Authors:  Sara Pescatori; Francesco Berardinelli; Jacopo Albanesi; Paolo Ascenzi; Maria Marino; Antonio Antoccia; Alessandra di Masi; Filippo Acconcia
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

Review 9.  SUMOylation in Viral Replication and Antiviral Defense.

Authors:  Yao Fan; Xiang Li; Lei Zhang; Zhi Zong; Fangwei Wang; Jun Huang; Linghui Zeng; Chong Zhang; Haiyan Yan; Long Zhang; Fangfang Zhou
Journal:  Adv Sci (Weinh)       Date:  2022-01-21       Impact factor: 16.806

Review 10.  Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review).

Authors:  Ling Wang; Jinjun Qian; Ye Yang; Chunyan Gu
Journal:  Int J Oncol       Date:  2021-08-09       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.